IRadimed Quarterly Income Statements Chart
Quarterly
|
Annual
IRadimed Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 20,409,400 | 19,510,637 | 19,389,167 | 18,325,959 | 17,928,876 | 17,598,119 | 17,452,176 | 16,504,640 | 16,130,396 | 15,475,083 | 23,361,424 | 13,407,272 | 12,721,569 | 12,310,710 | 18,643,252 | 10,907,302 | 9,810,423 | 9,223,996 | 8,546,043 | 7,699,096 | 6,794,692 | 8,677,541 | 10,890,653 | 9,963,299 | 9,225,596 | 8,437,593 | 8,339,392 | 7,614,655 | 7,376,785 | 7,108,151 | 6,704,944 | 5,689,724 | 5,524,364 | 5,162,560 | 5,990,273 | 7,673,217 | 9,868,905 | 8,964,153 | 8,799,256 | 8,193,616 | 7,609,143 | 6,991,705 | 3,583,504 | 3,811,947 | 4,700,369 |
yoy | 13.84% | 10.87% | 11.10% | 11.04% | 11.15% | 13.72% | -25.29% | 23.10% | 26.80% | 25.70% | 25.31% | 22.92% | 29.67% | 33.46% | 118.15% | 41.67% | 44.38% | 6.30% | -21.53% | -22.73% | -26.35% | 2.84% | 30.59% | 30.84% | 25.06% | 18.70% | 24.38% | 33.83% | 33.53% | 37.69% | 11.93% | -25.85% | -44.02% | -42.41% | -31.92% | -6.35% | 29.70% | 28.21% | 145.55% | 114.95% | 61.88% | ||||
qoq | 4.61% | 0.63% | 5.80% | 2.21% | 1.88% | 0.84% | 5.74% | 2.32% | 4.23% | -33.76% | 74.24% | 5.39% | 3.34% | -33.97% | 70.92% | 11.18% | 6.36% | 7.93% | 11.00% | 13.31% | -21.70% | -20.32% | 9.31% | 8.00% | 9.34% | 1.18% | 9.52% | 3.22% | 3.78% | 6.01% | 17.84% | 2.99% | 7.01% | -13.82% | -21.93% | -22.25% | 10.09% | 1.87% | 7.39% | 7.68% | 8.83% | 95.11% | -5.99% | -18.90% | |
cost of revenue | 4,454,408 | 4,667,831 | 4,628,308 | 4,134,253 | 3,919,283 | 4,210,396 | 4,039,236 | 3,667,256 | 3,943,904 | 3,753,635 | 4,879,195 | 2,864,534 | 2,581,806 | 2,931,186 | 3,728,303 | 2,501,745 | 2,478,122 | 2,161,680 | 2,106,609 | 1,958,036 | 1,864,587 | 2,213,730 | 2,741,838 | 2,168,208 | 1,858,288 | 2,047,827 | 1,982,492 | 1,826,716 | 1,710,890 | 1,691,535 | 1,640,197 | 1,307,767 | 1,234,314 | 1,387,618 | 1,304,088 | 1,405,884 | 1,739,067 | 1,705,797 | 1,499,978 | 1,590,222 | 1,422,027 | 1,328,180 | 918,696 | 959,593 | 869,745 |
gross profit | 15,954,992 | 14,842,806 | 14,760,859 | 14,191,706 | 14,009,593 | 13,387,723 | 13,412,940 | 12,837,384 | 12,186,492 | 11,721,448 | 18,482,229 | 10,542,738 | 10,139,763 | 9,379,524 | 14,914,949 | 8,405,557 | 7,332,301 | 7,062,316 | 6,439,434 | 5,741,060 | 4,930,105 | 6,463,811 | 8,148,815 | 7,795,091 | 7,367,308 | 6,389,766 | 6,356,900 | 5,787,939 | 5,665,895 | 5,416,616 | 5,064,747 | 4,381,957 | 4,290,050 | 3,774,942 | 4,686,185 | 6,267,333 | 8,129,838 | 7,258,356 | 7,299,278 | 6,603,394 | 6,187,116 | 5,663,525 | 2,664,808 | 2,852,354 | 3,830,624 |
yoy | 13.89% | 10.87% | 10.05% | 10.55% | 14.96% | 14.22% | -27.43% | 21.77% | 20.19% | 24.97% | 23.92% | 25.43% | 38.29% | 32.81% | 131.62% | 46.41% | 48.73% | 9.26% | -20.98% | -26.35% | -33.08% | 1.16% | 28.19% | 34.68% | 30.03% | 17.97% | 25.51% | 32.09% | 32.07% | 43.49% | 8.08% | -30.08% | -47.23% | -47.99% | -35.80% | -5.09% | 31.40% | 28.16% | 173.91% | 131.51% | 61.52% | ||||
qoq | 7.49% | 0.56% | 4.01% | 1.30% | 4.65% | -0.19% | 4.48% | 5.34% | 3.97% | -36.58% | 75.31% | 3.97% | 8.11% | -37.11% | 77.44% | 14.64% | 3.82% | 9.67% | 12.16% | 16.45% | -23.73% | -20.68% | 4.54% | 5.81% | 15.30% | 0.52% | 9.83% | 2.15% | 4.60% | 6.95% | 15.58% | 2.14% | 13.65% | -19.45% | -25.23% | -22.91% | 12.01% | -0.56% | 10.54% | 6.73% | 9.24% | 112.53% | -6.58% | -25.54% | |
gross margin % | 78.17% | 76.08% | 76.13% | 77.44% | 78.14% | 76.07% | 76.86% | 77.78% | 75.55% | 75.74% | 79.11% | 78.63% | 79.71% | 76.19% | 80.00% | 77.06% | 74.74% | 76.56% | 75.35% | 74.57% | 72.56% | 74.49% | 74.82% | 78.24% | 79.86% | 75.73% | 76.23% | 76.01% | 76.81% | 76.20% | 75.54% | 77.02% | 77.66% | 73.12% | 78.23% | 81.68% | 82.38% | 80.97% | 82.95% | 80.59% | 81.31% | 81.00% | 74.36% | 74.83% | 81.50% |
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||
general and administrative | 4,279,993 | 4,610,832 | 3,873,152 | 3,967,799 | 4,104,961 | 3,991,211 | 4,273,454 | 3,615,020 | 3,313,080 | 3,920,510 | 3,449,805 | 2,881,590 | 2,402,795 | 2,715,950 | -290,627 | 2,252,274 | 2,564,619 | 2,430,369 | 2,206,990 | 2,196,935 | 5,002,427 | 2,862,727 | 2,968,476 | 2,609,722 | 2,460,372 | 2,412,696 | 2,147,155 | 2,181,839 | 2,078,356 | 2,303,532 | 2,152,692 | 2,551,290 | 2,189,925 | 2,107,257 | 1,577,849 | 1,869,927 | 3,088,205 | 2,259,722 | 2,140,810 | 1,675,784 | 1,985,269 | 1,968,017 | 1,331,922 | 1,261,872 | 1,130,484 |
sales and marketing | 4,009,640 | 4,176,273 | 4,517,497 | 3,795,320 | 3,476,460 | 3,827,165 | 3,329,218 | 2,864,469 | 2,948,425 | 2,999,976 | 5,245,007 | 3,037,209 | 2,907,788 | 3,069,556 | 3,465,546 | 2,585,702 | 2,469,777 | 2,379,124 | 3,068,700 | 2,282,491 | 2,374,134 | 2,433,567 | 2,562,113 | 2,297,002 | 2,199,823 | 2,110,652 | 2,049,188 | 1,784,418 | 1,516,044 | 1,645,936 | 1,562,743 | 1,251,901 | 1,323,539 | 1,364,776 | 1,238,898 | 1,346,742 | 1,409,758 | 1,283,048 | 1,306,396 | 1,206,203 | 1,104,682 | 1,088,696 | 792,101 | 880,711 | 864,519 |
research and development | 877,362 | 624,245 | 569,993 | 639,467 | 801,129 | 821,000 | 650,435 | 452,555 | 961,952 | 793,716 | 867,889 | 491,643 | 662,599 | 519,095 | 515,231 | 480,696 | 453,679 | 475,817 | 512,718 | 476,876 | 482,654 | 430,282 | 379,310 | 369,526 | 331,310 | 352,573 | 367,715 | 373,583 | 395,988 | 379,826 | 349,559 | 382,704 | 449,011 | 541,290 | 364,216 | 457,134 | 291,822 | 234,336 | 499,996 | 518,562 | 403,447 | 342,301 | 315,407 | 303,463 | 225,500 |
total operating expenses | 9,166,995 | 9,411,350 | 8,960,642 | 8,402,586 | 8,382,550 | 8,639,376 | 8,253,107 | 6,932,044 | 7,223,457 | 7,714,202 | 9,562,701 | 6,410,442 | 5,973,182 | 6,304,601 | 3,690,150 | 5,318,672 | 5,488,075 | 5,285,310 | 5,788,408 | 4,956,302 | 7,859,215 | 5,726,576 | 5,909,899 | 5,276,250 | 4,991,505 | 4,875,921 | 4,564,058 | 4,339,840 | 3,990,388 | 4,329,294 | 4,064,994 | 4,185,895 | 3,962,475 | 4,013,323 | 3,180,963 | 3,673,803 | 4,789,785 | 3,777,106 | 3,947,202 | 3,400,549 | 3,493,398 | 3,399,014 | 2,439,430 | 2,446,046 | 2,220,503 |
income from operations | 6,787,997 | 5,431,456 | 5,800,217 | 5,789,120 | 5,627,043 | 4,748,347 | 5,159,833 | 5,905,340 | 4,963,035 | 4,007,246 | 8,919,528 | 4,132,296 | 4,166,581 | 3,074,923 | 11,224,799 | 3,086,885 | 1,844,226 | 1,777,006 | 651,026 | 784,758 | -2,929,110 | 737,235 | 2,238,916 | 2,518,841 | 2,375,803 | 1,513,845 | 1,792,842 | 1,448,099 | 1,675,507 | 1,087,322 | 999,753 | 196,062 | 327,575 | 1,505,222 | 2,593,530 | 3,340,053 | 3,481,250 | 3,352,076 | 3,202,845 | 2,693,718 | 2,264,511 | 225,378 | 406,308 | 1,610,121 | |
yoy | 20.63% | 14.39% | 12.41% | -1.97% | 13.38% | 18.49% | -42.15% | 42.91% | 19.12% | 30.32% | -20.54% | 33.87% | 125.93% | 73.04% | 1624.17% | 293.36% | -162.96% | 141.04% | -70.92% | -68.84% | -223.29% | -51.30% | 24.88% | 73.94% | 41.80% | 39.23% | 79.33% | 638.59% | 411.49% | -33.58% | -92.44% | -90.19% | -55.10% | -19.02% | 23.99% | 53.73% | 1387.31% | 688.28% | 67.30% | ||||||
qoq | 24.98% | -6.36% | 0.19% | 2.88% | 18.51% | -7.97% | -12.62% | 18.99% | 23.85% | -55.07% | 115.85% | -0.82% | 35.50% | -72.61% | 263.63% | 67.38% | 3.78% | 172.95% | -17.04% | -126.79% | -497.31% | -67.07% | -11.11% | 6.02% | 56.94% | -15.56% | 23.81% | -13.57% | 54.09% | 8.76% | 409.92% | -40.15% | -41.96% | -22.35% | -4.06% | 3.85% | 4.66% | 18.90% | 18.95% | 904.76% | -44.53% | -74.77% | |||
operating margin % | 33.26% | 27.84% | 29.91% | 31.59% | 31.39% | 26.98% | 29.57% | 35.78% | 30.77% | 25.89% | 38.18% | 30.82% | 32.75% | 24.98% | 60.21% | 28.30% | 18.80% | 19.27% | 7.62% | 10.19% | -43.11% | 8.50% | 20.56% | 25.28% | 25.75% | 17.94% | 21.50% | 19.02% | 22.71% | 15.30% | 14.91% | 3.45% | 5.93% | 25.13% | 33.80% | 33.84% | 38.84% | 38.09% | 39.09% | 35.40% | 32.39% | 6.29% | 10.66% | 34.26% | |
other income | 539,247 | 513,973 | 544,160 | 629,201 | 642,217 | 495,154 | 521,810 | 503,192 | 335,387 | 342,409 | 13,102 | 14,915 | -107,101 | 7,143 | 13,195 | -5,663 | 13,507 | 9,352 | 17,852 | 98,502 | 115,249 | 110,064 | 78,025 | 92,574 | 83,072 | 42,555 | 27,838 | 40,072 | 32,000 | 28,715 | 21,138 | 29,524 | 9,588 | 31,778 | -36,275 | 64,709 | 46,135 | 46,815 | 1,568.75 | 11,631 | |||||
income before benefit from income taxes | 7,327,244 | 5,945,429 | 6,344,377 | 6,418,321 | 6,269,260 | 5,243,501 | 5,681,643 | 6,408,532 | 5,298,422 | 4,349,655 | 1,680,698 | 4,237,479 | 4,179,683 | 3,060,008 | 11,117,698 | 3,094,028 | 1,857,421 | 1,771,343 | 664,533 | 794,110 | -2,911,258 | 835,737 | 2,354,165 | 2,628,905 | 2,453,828 | 1,606,419 | 1,875,914 | 1,490,654 | 1,703,345 | 1,127,394 | 1,031,753 | 224,777 | 348,713 | 1,514,810 | 2,589,513 | 3,335,384 | 3,513,028 | 3,315,801 | 3,267,554 | 2,739,853 | 2,311,326 | 170,554 | 397,500 | 1,621,752 | |
benefit from income tax expense | 1,553,283 | 1,258,000 | 1,197,599 | 1,368,830 | 1,368,036 | 1,106,968 | 1,141,957 | 1,341,352 | 1,118,582 | 943,589 | 2,062,274 | 810,375 | 938,631 | 573,295 | 74,969 | 174,035 | 364,987 | 348,377 | 286,198 | 12,126.75 | 32,384 | 24,483 | |||||||||||||||||||||||
net income | 5,773,961 | 4,687,429 | 5,146,778 | 5,049,491 | 4,901,224 | 4,136,533 | 4,539,686 | 5,067,180 | 4,179,840 | 3,406,066 | 7,395,683 | 3,427,104 | 3,241,052 | 2,486,713 | 8,593,884 | 2,576,261 | 1,469,694 | 1,386,849 | 637,414 | 1,074,646 | -2,112,270 | 1,769,211 | 3,241,683 | 2,454,870 | 2,088,841 | 1,845,565 | 1,707,013 | 2,400,273 | 1,354,968 | 841,196 | 183,638 | 192,393 | 357,073 | -233,340 | 1,140,800 | 1,560,484 | 2,231,251 | 2,282,011 | 2,404,706 | 1,867,148 | 1,770,571 | 1,487,495 | 270,821 | 237,357 | 1,018,821 |
yoy | 17.81% | 13.32% | 13.37% | -0.35% | 17.26% | 21.45% | -38.62% | 47.86% | 28.97% | 36.97% | -13.94% | 33.03% | 120.53% | 79.31% | 1248.24% | 139.73% | -169.58% | -21.61% | -80.34% | -56.22% | -201.12% | -4.14% | 89.90% | 2.27% | 54.16% | 119.40% | 829.55% | 1147.59% | 279.47% | -460.50% | -83.90% | -87.67% | -84.00% | -110.23% | -52.56% | -16.42% | 26.02% | 53.41% | 787.93% | 686.64% | 73.79% | ||||
qoq | 23.18% | -8.92% | 1.93% | 3.03% | 18.49% | -8.88% | -10.41% | 21.23% | 22.72% | -53.95% | 115.80% | 5.74% | 30.33% | -71.06% | 233.58% | 75.29% | 5.97% | 117.57% | -40.69% | -150.88% | -219.39% | -45.42% | 32.05% | 17.52% | 13.18% | 8.12% | -28.88% | 77.15% | 61.08% | 358.07% | -4.55% | -46.12% | -253.03% | -120.45% | -26.89% | -30.06% | -2.22% | -5.10% | 28.79% | 5.45% | 19.03% | 449.25% | 14.10% | -76.70% | |
net income margin % | 28.29% | 24.02% | 26.54% | 27.55% | 27.34% | 23.51% | 26.01% | 30.70% | 25.91% | 22.01% | 31.66% | 25.56% | 25.48% | 20.20% | 46.10% | 23.62% | 14.98% | 15.04% | 7.46% | 13.96% | -31.09% | 20.39% | 29.77% | 24.64% | 22.64% | 21.87% | 20.47% | 31.52% | 18.37% | 11.83% | 2.74% | 3.38% | 6.46% | -4.52% | 19.04% | 20.34% | 22.61% | 25.46% | 27.33% | 22.79% | 23.27% | 21.28% | 7.56% | 6.23% | 21.68% |
net income per share | |||||||||||||||||||||||||||||||||||||||||||||
basic | 0.45 | 0.37 | 0.41 | 0.4 | 0.39 | 0.33 | 0.36 | 0.4 | 0.33 | 0.27 | 0.58 | 0.27 | 0.26 | 0.2 | 0.7 | 0.21 | 0.12 | 0.11 | 0.05 | 0.09 | -0.17 | 0.15 | 0.28 | 0.22 | 0.19 | 0.17 | 0.16 | 0.22 | 0.13 | 0.08 | 0.02 | 0.02 | 0.03 | -0.02 | 0.11 | 0.15 | 0.21 | 0.21 | 0.21 | 0.17 | 0.16 | 0.14 | 0.01 | 0.02 | 0.15 |
diluted | 0.45 | 0.37 | 0.4 | 0.4 | 0.38 | 0.32 | 0.36 | 0.4 | 0.33 | 0.27 | 0.59 | 0.27 | 0.26 | 0.2 | 0.68 | 0.2 | 0.12 | 0.11 | 0.05 | 0.09 | -0.17 | 0.14 | 0.26 | 0.2 | 0.17 | 0.15 | 0.14 | 0.2 | 0.11 | 0.07 | 0.01 | 0.02 | 0.03 | -0.02 | 0.1 | 0.13 | 0.19 | 0.19 | 0.18 | 0.15 | 0.15 | 0.12 | 0.02 | 0.02 | 0.11 |
weighted-average shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||
basic | 12,715,872 | 12,714,224 | 12,670,216 | 12,669,741 | 12,664,920 | 12,662,526 | 12,602,948 | 12,602,581 | 12,596,032 | 12,593,033 | 12,562,856 | 12,564,636 | 12,560,812 | 12,552,817 | 12,346,173 | 12,331,062 | 12,313,563 | 12,310,577 | 12,123,556 | 12,243,362 | 12,076,399 | 11,891,428 | 11,282,214 | 11,369,404 | 11,163,506 | 11,029,639 | 10,758,752 | 10,824,421 | 10,651,619 | 10,608,387 | 10,638,858 | 10,565,598 | 10,687,746 | 10,740,979 | 10,818,427 | 10,684,650 | 10,778,673 | 11,095,950 | 11,003,272 | 11,028,551 | 10,974,448 | 10,906,224 | 8,743,461 | 10,112,139 | 7,000,000 |
diluted | 12,835,408 | 12,825,672 | 12,783,558 | 12,778,446 | 12,757,996 | 12,749,973 | 12,722,530 | 12,735,837 | 12,723,017 | 12,686,699 | 12,635,971 | 12,631,129 | 12,632,755 | 12,655,518 | 12,590,853 | 12,603,566 | 12,554,828 | 12,521,279 | 12,440,086 | 12,493,309 | 12,076,399 | 12,365,605 | 12,276,444 | 12,309,948 | 12,226,660 | 12,227,696 | 12,110,117 | 12,195,870 | 12,011,475 | 11,879,889 | 11,720,316 | 11,643,044 | 11,727,473 | 10,740,979 | 11,989,681 | 11,867,997 | 11,966,289 | 12,326,108 | 12,556,887 | 12,382,531 | 12,107,707 | 11,977,959 | 10,219,143 | 11,269,358 | 8,878,170 |
other income | 3,668.75 | 105,183 | |||||||||||||||||||||||||||||||||||||||||||
benefit from income tax benefit | 2,523,814 | 517,767 | 387,727 | 384,494 | -933,474 | ||||||||||||||||||||||||||||||||||||||||
benefit from income tax (benefit) expense | -503,249.5 | -280,536 | -798,988 | ||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | 374,010 | 1,029,029 | 1,104,133 | 1,231,017 | 911,095 | 1,400,406 | 969,282 | 823,831 | -100,267 | 160,143 | 602,931 | ||||||||||||||||||||||||||||||||||
other comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||
change in fair value of available-for-sale securities, net of tax (benefit) expense of (6,369) and 70 for the three months ended september 30, 2015 and 2014, respectively, and (8,833) and (2,681) for the nine months ended september 30, 2015 and 2014, respectively | |||||||||||||||||||||||||||||||||||||||||||||
realized gain on available-for-sale securities reclassified to net income, net of tax of 70 and 2,560 for the three and nine months ended september 30, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||||||
comprehensive income | 1,277,717.75 | 1,856,807 | 1,757,173 | 1,496,891 | 249,348 | 237,357 | 1,020,347 | ||||||||||||||||||||||||||||||||||||||
change in fair value of available-for-sale securities, net of tax (benefit) expense of (8,249) and 821 for the three months ended june 30, 2015 and 2014, respectively, and (2,464) and 1,993 for the six months ended june 30, 2015 and 2014, respectively | |||||||||||||||||||||||||||||||||||||||||||||
change in fair value of available-for-sale securities, net of tax expense of 5,785 and 1,171 for the three months ended march 31, 2015 and 2014, respectively | 9,396 | ||||||||||||||||||||||||||||||||||||||||||||
change in fair value of available-for-sale securities, net of tax benefit of 70 and (432) for the three months ended september 30, 2014 and 2013, respectively, and 2,063 and (2,681) for the nine months ended september 30, 2014 and 2013, respectively | 958 | 130 | |||||||||||||||||||||||||||||||||||||||||||
change in fair value of available-for-sale securities, net of tax benefit of 821 and (2,326) for the three months ended june 30, 2014 and 2013, respectively, and 1,993 and (2,249) for the six months ended june 30, 2014 and 2013, respectively | 1,526 |
We provide you with 20 years income statements for IRadimed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRadimed stock. Explore the full financial landscape of IRadimed stock with our expertly curated income statements.
The information provided in this report about IRadimed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.